{"data":[{"accessionNo":"0001231919-26-000928","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":32886242,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001231919-26-000928","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":32886242,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001231919-26-000928","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":32886242,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001231919-26-000928","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":32886242,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0000895421-26-000269","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":16244339,"percentOfClass":5.1,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0000895421-26-000269","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Morgan Stanley Capital Services LLC","reportingCik":null,"personType":"BD,CO","sharesOwned":16001130,"percentOfClass":5,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001493215-26-000122","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-03-31","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":20689084,"percentOfClass":7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001493215-26-000122","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-03-31","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":20689084,"percentOfClass":7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0000902664-26-002553","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-03-31","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":18000000,"percentOfClass":6.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0000902664-26-002553","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":"877619106","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-03-31","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":18000000,"percentOfClass":6.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001493215-26-000050","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":23407133,"percentOfClass":8.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001493215-26-000050","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":23407133,"percentOfClass":8.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0000902664-26-001081","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":13750000,"percentOfClass":5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0000902664-26-001081","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":13750000,"percentOfClass":5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0000315066-26-000536","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES INC","ticker":"TSHA","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":13528365.87,"percentOfClass":4.9,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0000315066-26-000536","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES INC","ticker":"TSHA","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":13528365.87,"percentOfClass":4.9,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0002012383-26-000794","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies Inc","ticker":"TSHA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":17852291,"percentOfClass":6.5,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001231919-25-000491","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":27662481,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001231919-25-000491","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":27662481,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001231919-25-000491","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":27662481,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001231919-25-000491","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001806310","issuerName":"TAYSHA GENE THERAPIES, INC.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":27662481,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001214659-25-016718","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2025-09-30","reportingPerson":"Octagon Investments Master Fund","reportingCik":null,"personType":"PN,OO","sharesOwned":9067500,"percentOfClass":3.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001214659-25-016718","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2025-09-30","reportingPerson":"Ting Jia","reportingCik":null,"personType":"HC,IN","sharesOwned":9067500,"percentOfClass":3.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"},{"accessionNo":"0001214659-25-016718","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001806310","issuerName":"Taysha Gene Therapies, Inc.","ticker":"TSHA","cusip":null,"securityClass":"Common Stock, $0.00001 par value","eventDate":"2025-09-30","reportingPerson":"Octagon Capital Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":9067500,"percentOfClass":3.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/tsha"}],"updatedAt":"2026-11-05T00:17:35.923Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/tsha","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}